PIK3CA Genotype and Treatment Decisions in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

MLA

Philippe L. Bedard, and David W. Cescon. “PIK3CA Genotype and Treatment Decisions in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer.” Journal of Clinical Oncology, vol. 33, Apr. 2015, pp. 1318–21. EBSCOhost, https://doi.org/10.1200/jco.2014.59.3160.

APA

Philippe L. Bedard, & David W. Cescon. (2015). PIK3CA Genotype and Treatment Decisions in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer. Journal of Clinical Oncology, 33, 1318–1321. https://doi.org/10.1200/jco.2014.59.3160

Chicago

Philippe L. Bedard, and David W. Cescon. 2015. “PIK3CA Genotype and Treatment Decisions in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer.” Journal of Clinical Oncology 33 (April): 1318–21. doi:10.1200/jco.2014.59.3160.